Complementary and Integrative Medicine Use among Migraine Patients Using a Modified Version of I-CAM-QP: A Cross-Sectional Study
Abstract
This study aimed to determine the prevalence and associated factors of complementary and alternative medicine (CAM) use among patients with migraine using a culturally-adapted Persian version of the International Complementary and Alternative Medicine Questionnaire (I-CAM-QP). In this cross-sectional study, 310 patients attending two neurology referral clinics were screened. After excluding 66 individuals who did not meet International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria and three incomplete questionnaires, 241 patients with ICHD-3–confirmed migraine were analyzed. The core four domains of the I-CAM-QP were preserved (CAM providers, practitioner-based therapies, herbal/supplement use, and self-help practices). Modifications were limited to contextual adaptation and included the addition of migraine-specific clinical variables, incorporation of locally prevalent Traditional Persian Medicine modalities (e.g., cupping, phlebotomy, leech therapy, lifestyle modification), reinstatement and expansion of provider categories to distinguish physician and non-physician practitioners, and supplementary items assessing disclosure and safety-related aspects of CAM use. Participants were predominantly female (78.4%), with a mean age of 38.10 ± 10.18 years and mean disease duration of 10.77 ± 8.7 years. Overall, 91.7% reported using at least one CAM modality in the preceding 12 months. Herbal medicines and dietary supplements were most common (86.7%), with herbs alone reported by 68%. Increasing age was independently associated with higher odds of total CAM use among patients with episodic migraine (AOR 1.08; 95% CI 1.00–1.16) and self-help CAM practices (AOR per year increase: 1.03; 95% CI: 1.00–1.06). Greater mean headache pain intensity was independently associated with visiting a CAM provider (AOR 1.22; 95% CI 1.02–1.47). Additionally episodic migraine was associated with self-help practices (AOR: 2.45; 95% CI: 1.22–4.09). CAM use was highly prevalent and largely self-directed, underscoring the need for structured patient–physician communication in routine migraine care.
Steiner TJ, Stovner LJ, Jensen, Uluduz RD, Katsarava Z, et al. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD 2019. J Headache Pain 2020;21:1-4.
Feigin VL, Vos T, Alahdab F, Amit AML, Bärnighausen TW, et al. GBD 2017 US neurological disorders collaborators. burden of neurological disorders across the US from 1990-2017: a global burden of disease study. JAMA Neurol 2021;78:165-176.
Gantenbein AR, Agosti R, Kamm CP, Landmann G, Meier N, et al. Swiss quality of life and healthcare impact assessment in a real-world erenumab treated migraine population (square study): interim results. J Headache Pain 2022;23:1-10.
Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 2017;372:307-315.
Liu X, Yang W, Zhu C, Sun S, Wu S, et al. Toll-like receptors and their role in neuropathic pain and migraine. Mol Brain 2022;15:1-9.
Martelletti P, Luciani M, Spuntarelli V, Bentivegna E. Deprescribing in migraine. Expert Opin Drug Saf 2021;20:623-625.
Traditional, Complementary and Integrative Medicine. Available from https://www.who.int/health-topics/traditional-complementary-and-integrative-medicine#tab=tab_1. [Accessed 8 September 2020].
Xu J, Zhang Y. Traditional Chinese medicine treatment of COVID-19. Complement Ther Clin Pract 2020;39:101165.
Yazdi N, Salehi A, Vojoud M, Sharifi MH, Hoseinkhani A. Use of complementary and alternative medicine in pregnant women: A cross-sectional survey in the south of Iran. J Integr Med 2019;17:392-395.
Kristoffersen AE, Quandt SA, Stub T. Use of complementary and alternative medicine in Norway: a cross-sectional survey with a modified Norwegian version of the international questionnaire to measure use of complementary and alternative medicine (I-CAM-QN). BMC Complement Med Ther 2021;21:1-12.
Farhoudi F, Zohalinezhad ME, Zarshenas MM, Masoudi N, Abarghooei EF, et al. Possible protective effect of Zataria multiflora Boiss. on salivary glands in patients with differentiated thyroid carcinoma treated with radioiodine: A randomized, double-blind, placebo-controlled clinical trial. Iran J Nucl Med 2024;32:16.
Ashraf H, Salehi A, Sousani M, Sharifi MH . Use of complementary alternative medicine and the associated factors among patients with depression. Evid Based Complement Alternat Med 2021;1.
Kristoffersen AE, Stub T, Musial F, Fønnebø V, Lillenes O, et al. Prevalence and reasons for intentional use of complementary and alternative medicine as an adjunct to future visits to a medical doctor for chronic disease. BMC Complement Alternat Med 2018;18:1-8.
Steel A, McIntyre E, Harnett J, Foley A, Adams J, et al. Complementary medicine use in the Australian population: Results of a nationally-representative cross-sectional survey. Sci Rep 2018;8:1-7.
Korucu O, Atasoy HT, Demiryürek BE, Emre U, Taşçılar F N, et al.The use of complemantary and alternative treatment in headache patients. Gazi Med J 2018;29:183-186.
Kuruvilla DE, Mehta A, Ravishankar N, Cowan RP. A patient perspective of complementary and integrative medicine (CIM) for migraine treatment: a social media survey. BMC Complement Med Ther 2021;21:1-7.
Polat B, Saatci O, Yilmaz NH, Duz OA. The frequency of complementary and integrative medicine methods in headache patients and their spending habits. Neurologia i Neurochirurgia Polska 2018;52:347-351.
Patel PS, Minen MT. Complementary and integrative health treatments for migraine. J Neuroophthalmol 2019;39:360-369.
Göksel BK, Coşkun Ö, Ucler S, Karatas M, Ozge A, et al. Use of complementary and alternative medicine by a sample of Turkish primary headache patients.
Al-Hashel JY, Ahmed SF, Alshawaf F, Alroughani R. Use of traditional medicine for primary headache disorders in Kuwait. J Headache Pain 2018;19:1-7.
Quandt SA, Verhoef MJ, Arcury TA, Lewith GT, Steinsbekk A, et al. A Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med 2009;15:331-339.
Esteban S, Vázquez Peña F, Terrasa S. Translation and cross-cultural adaptation of a standardized international questionnaire on use of alternative and complementary medicine (I-CAM - Q) for Argentina. BMC Complement Altern Med 2016;16:1-7.
Farhoudi F, Salehi A, Vojoud M, Molavi Vardanjani H. Assessment of the complementary and integrative medicine utilization among patients with multiple sclerosis using a translated and adapted version of the international questionnaire (I-CAM-QP): A cross-sectional study in Southern Iran. Complement Ther Med 2019;46:47-53.
Druart L, Pinsault N. The I-CAM-FR: a french translation and cross-cultural adaptation of the I-CAM-Q Medicines 2018;5:72.
Jones CW, Remboski LB, Freeze B, Braz VA, Gaughan JP, et al. Intravenous fluid for the treatment of emergency department patients with migraine headache: a randomized controlled trial. Ann Emerg Med 2019;73:150-156.
Franik S, Huidekoper HH, Visser G, Vries M de, Boer L de, et al. High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders. J Inherit Metab Dis 2015;38:477-482.
Santiago-Garcia AP, Gamez-Nava JI, Avalos-Salgado FA, Cerpa-Cruz S, Amaya-Cabrera EL, et al. Complementary therapies and their association with problems in therapeutic adherence to conventional synthetic DMARDs in rheumatoid arthritis: A cross-sectional study. Healthcare (Basel) 2023;11.
Cevik C, Selcuk KT. Prevalence and correlates of the use of complementary and alternative medicine in adults living in a rural area. Holist Nurs Pract 2019;33:36-44.
Tai M-LS, Yap JF, Chin HL, Tan CT, Goh CBJNA. Complementary and alternative medicine for migraine and tension-type headache among the Malaysians. Neurol Asia 2020;25.
Sadiq S, Singh BP, Kalsotra M, Bhagat V, Choudhary S. Complementary and alternative medicines use among adults with migraine in a tertiary care hospital: An observational study. Natl J Physiol Pharm Pharmacol 2022;12:737-737.
Wemrell M, Merloa J, Mulinaria S, Hornborgd AC. Two-thirds of survey respondents in southern Sweden used complementary or alternative medicine in 2015. Complement Med Res 2017;24:302-309.
Chung VC, Ma PH, Wang HH, Wang JJ, Hong LC, et al. Integrating traditional chinese medicine services in community health centers: insights into utilization patterns in the pearl river region of China. Evid Based Complement Alternat Med 2013;2013.
Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med 2015;13:319-325
Ayele AA, Tegegn HG, Haile KT, Belachew SA, Mersha AG, et al. Complementary and alternative medicine use among elderly patients living with chronic diseases in a teaching hospital in Ethiopia. Complement Ther Med 2017;35:115-119.
Lee J, Bhowmick A,Wachholtz A. Does complementary and alternative medicine (CAM) use reduce negative life impact of headaches for chronic migraineurs? A national survey. SpringerPlus 2016;5:1-10.
Mulder LTC, Busch M, Kristoffersen AE, Hök Nordberg J, van der Werf ET. Prevalence and predictive factors of complementary medicine use during the first wave of the COVID-19 pandemic of 2020 in the Netherlands. BMC Complement Med Ther 2022;22:1-10.
Makarevičius G, Dapkutė A, Ryliškienė K. Complementary and alternative medicine use in migraine patients: Results from a national patient e-survey. Front Neurol 2024;15:1378532.
Drieskens S, Tafforeau J, Demarest S. Do sociodemographic characteristics associated with the use of CAM differ by chronic disease? Eur J Public Health 2019;29:655-660.
Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, et al. Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study. Headache 2012;52:1456-1470.
Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, et al. Global prevalence of chronic migraine: A systematic review. Cephalalgia 2010;30:599-609.
Rossi P, Di Lorenzo G, Malpezzi M, Faroni J, Cesarino F, et al. Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia 2005;25:493-506.
Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache 2011;51:1087-1097.
James PB, Wardle J, Steel A, Adams J. Traditional, complementary and alternative medicine use in Sub-Saharan Africa: A systematic review. BMJ Glob Health 2018;3:e000895.
de Moraes Mello Boccolini P, Siqueira Boccolini C. Prevalence of complementary and alternative medicine (CAM) use in Brazil. BMC Complement Med Ther 2020;20:1-10.
Judson PL, Abdallah R, Xiong Y, Ebbert J, Lancaster JM.. Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center. Integr Cancer Ther 2017;16:96-103.
Foley H, Steel A, Cramer H, Wardle J, Adams J. Disclosure of complementary medicine use to medical providers: A systematic review and meta-analysis. Sci Rep 2019;9:1573.
Jou J, Johnson PJ. Nondisclosure of complementary and alternative medicine use to primary care physicians: Findings from the 2012 National Health Interview Survey. JAMA Intern Med 2016;176:545-546.
Foley H, Steel A, McIntyre E, Harnett J, Sibbritt D, et al. Disclosure of conventional and complementary medicine use to medical doctors and complementary medicine practitioners: A survey of rates and reasons amongst those with chronic conditions. PLoS One 2021;16:e0258901.
Alzahrani AS, Price MJ, Greenfield SM, Paudyal V. Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: Systematic review and meta-analysis. Eur J Clin Pharmacol 2021;77:1259-1274.
| Issue | Vol. 11, No. 2, 2026 -In Press- | |
| Section | Research Article(s) | |
| Keywords | ||
| Complementary and alternative medicine H5eadache I-CAM-Q I-CAM-QP Migraine headache Persian medicine | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |


